<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00619593</url>
  </required_header>
  <id_info>
    <org_study_id>TA079</org_study_id>
    <nct_id>NCT00619593</nct_id>
  </id_info>
  <brief_title>Survival of Patients With Primary Prophylactic ICD Indication</brief_title>
  <acronym>SPIRIT-ICD</acronym>
  <official_title>Survival of Patients With Primary Prophylactic ICD Indication, Provided With Intensified Care After 1st ICD Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The MADIT-II trial has shown that patients with severely reduced left ventricular ejection
      fraction (LVEF) post myocardial infarction benefit from the implantable
      cardioverter-defibrillator (ICD). However, retrospective analyses of the MADIT-II data have
      revealed a significantly increased morbidity and mortality in patients with appropriate ICD
      therapy: Appropriate ICD therapy is associated with 3.3-fold increased all-cause mortality,
      and the risk of a first heart failure hospitalization is 90% higher after 1st appropriate ICD
      therapy. Hence, the 1st appropriate therapy might indicate the necessity and utility of
      further clinical diagnostics and therapy in these patients.

      This trial is designed to (i) improve the knowledge of the group characteristics of patients
      suffering from 1st appropriate ICD therapy, (ii) but moreover to take additional therapeutic
      steps to reduce the mortality of this patient population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The MADIT-II trial has shown that patients with severely reduced left ventricular ejection
      fraction (LVEF) post myocardial infarction benefit from the implantable
      cardioverter-defibrillator (ICD). However, retrospective analyses of the MADIT-II data have
      revealed a significantly increased morbidity and mortality in patients with appropriate ICD
      therapy: Appropriate ICD therapy is associated with 3.3-fold increased all-cause mortality,
      and the risk of a first heart failure hospitalization is 90% higher after 1st appropriate ICD
      therapy. Hence, the 1st appropriate therapy might indicate the necessity and utility of
      further clinical diagnostics and therapy in these patients.

      This trial is designed to (i) improve the knowledge of the group characteristics of patients
      suffering from 1st appropriate ICD therapy, (ii) but moreover to take additional therapeutic
      steps to reduce the mortality of this patient population.

      After standard ICD implantation procedure, the following steps are performed at the
      pre-discharge follow-up:

        -  Programming: VR-T: VVI 40 ppm, Onset 20%, Stability 20 ms

        -  DR-T: DDD 50-60 ppm, activation of IRSplus and SMART

        -  HF-T: DDD-BiV 50-60 ppm, achieve at least 85% biventricular resynchronisation,
           activation of SMART

        -  All devices: VT zone as therapy zone, VF zone. Programming recommendations for VT/VF
           zones to standardize treatment:

             -  VF zone: 200-250 bpm/ 300-240 ms, ATPoneshot ON

             -  VT1 zone: 167-200 bpm/ 360-300 ms, ATP ON

             -  VT2 zone: 120-167 bpm/ 500-360 ms, ATP ON

        -  Activation of Home Monitoring (HM) and online registration for HM service

      Standard Follow-up: Timing and scope of follow-up in patients without episodes is to the
      physician's own discretion and should follow the standard clinical routine.

      Follow-up after 1st appropriate ICD therapy: Immediately after having received the 1st
      appropriate ICD therapy, the patients have to be called to the clinic for intensified
      clinical diagnostics and, if necessary or useful, intensified therapy. Standard ICD follow-up
      has to be started within 72 hours after 1st appropriate ICD therapy.

        -  ICD interrogation

        -  General health status (weight, BP, NYHA)

        -  Laboratory tests (hemoglobin, Nt-proBNP, creatinine, GDF-15)

        -  Echocardiography (LVEF, LVEDD, mitral regurgitation)

        -  Non-invasive ischemia evaluation

        -  Coronary angiography (if indicated by ischemia evaluation)

        -  Upgrade to CRT, if indicated

        -  Ventricular ablation (if indicated: VT storm, slow VT, bundle branch reentry)

        -  24 hrs ECG Holter (Heart rate variability)

        -  Further treatment (if applicable)

        -  Changes in ICD settings, or medication

        -  Adverse events / adverse device effects

      Final follow-up visit: For patients without appropriate ICD therapy, the final follow-up
      shall be performed 12 months after enrolment.

      For patients with appropriate ICD therapy, the final follow-up shall be performed 12 months
      after 1st appropriate ICD therapy.

      The final follow-up visit comprises:

        -  ICD interrogation

        -  General health status (weight, BP, NYHA)

        -  Echocardiography (LVEF, LVEDD, mitral regurgitation)

        -  Laboratory tests (hemoglobin, Nt-proBNP, creatinine, GDF-15)

        -  24 hrs ECG Holter (Heart rate variability)

        -  Further treatment (if applicable)

        -  Changes in ICD settings, or medication

        -  Adverse events / adverse device effects
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2008</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sudden cardiac death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-sudden cardiac death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Risk of 1st heart failure hospitalization</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No. of VT Storms (&gt; 3 VT/24h)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>No. of delivered ICD therapies</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">504</enrollment>
  <condition>Primary Prevention</condition>
  <condition>Tachycardia, Ventricular</condition>
  <condition>Sudden Cardiac Death</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard follow-up in patients without appropriate ICD therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Following 1st appropriate ICD therapy, the patients have to be called to the clinic for intensified clinical diagnostics and, if necessary or useful, intensified therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Intensified diagnostic and treatment measures following 1st appropriate ICD therapy</intervention_name>
    <description>Assessment of general health status (weight, BP, NYHA)
Laboratory tests (hemoglobin, Nt-proBNP, creatinine, GDF-15)
Echocardiography (LVEF, LVEDD, mitral regurgitation)
Non-invasive ischemia evaluation
Coronary angiography (if indicated by ischemia evaluation)
Upgrade to CRT, if indicated
Ventricular ablation (if indicated: VT storm, slow VT, bundle branch reentry)
24 hrs ECG Holter (Heart rate variability)
Further treatment (if applicable)
Changes in ICD settings, or medication</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Intensified diagnostic and treatment measures</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard follow-up</intervention_name>
    <description>Standard follow-up in patients without appropriate ICD therapy</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for ICD implantation according to MADIT-II:

               -  Myocardial infarction 30 days or more before implantation

               -  LVEF of 30% or less within 3 months before implantation

          -  Angiography within the preceding 12 months

          -  The patient is willing and able to comply with the clinical investigation plan and has
             provided written informed consent

        Exclusion Criteria:

          -  Patients with contraindication for ICD implantation

          -  Conventional ICD indication (i.e. other than MADIT-II)

          -  Myocardial infarction within the past 30 days

          -  Coronary revascularisation within the preceding 3 months (i.e., if revascularization
             has been performed wait at least 3 months until enrolment, given that no appropriate/
             inappropriate ICD therapy has occured)

          -  NYHA functional class IV

          -  Unexplained syncope within 3 years

          -  Advanced cerebrovascular disease

          -  Life expectancy very probably below 12 months

          -  Pregnant or breast-feeding women

          -  Age &lt; 18 years

          -  Patients who are already enrolled in another study (therapy/intervention phase)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Hatala, Prof. MUDr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Národný ústav srdcových a cievnych chorôb, Kardiologická klinika, Pod Krásnou Hôrkou 1, 833 48 Bratislava, Slovakia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>A.ö. Krankenhaus der Stadt Linz</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landesklinikum St. Pölten</name>
      <address>
        <city>St. Poelten</city>
        <zip>3100</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wilhelminenspital der Stadt Wien</name>
      <address>
        <city>Wien</city>
        <zip>1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brno Bohunice</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice u Svety Anny</name>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>FN Olomouc, Inerni klinika</name>
      <address>
        <city>Olomouc</city>
        <zip>77520</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Online 24 S.R.O.</name>
      <address>
        <city>Praha</city>
        <zip>12000</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of clinical and experimental medicine</name>
      <address>
        <city>Praha</city>
        <zip>1421</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital RWTH Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>52074</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefäss-Klinik GmbH Bad Neustadt</name>
      <address>
        <city>Bad Neustadt</city>
        <zip>97616</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bielefeld</name>
      <address>
        <city>Bielefeld</city>
        <zip>33604</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Marien Hospital</name>
      <address>
        <city>Bonn</city>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Detmold Lippe</name>
      <address>
        <city>Detmold</city>
        <zip>32756</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Mitte</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <zip>01067</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40217</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hermann-Josef-Krankenhaus</name>
      <address>
        <city>Erkelenz</city>
        <zip>41812</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Justus Liebig Universität Gießen</name>
      <address>
        <city>Gießen</city>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Landshut-Achdorf</name>
      <address>
        <city>Landshut</city>
        <zip>84034</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus St. Franziskus</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincenz Krankenhaus</name>
      <address>
        <city>Paderborn</city>
        <zip>33098</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>18055</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Katharinenhospital</name>
      <address>
        <city>Unna</city>
        <zip>59423</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Semmelweis University</name>
      <address>
        <city>Budapest</city>
        <zip>1122</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The University of Medicine Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>4012</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chaim Sheba Medical Center</name>
      <address>
        <city>Tel Hashomer</city>
        <zip>52621</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Latvian Center of Cardiology</name>
      <address>
        <city>Riga</city>
        <zip>1002</zip>
        <country>Latvia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Health Waikato, Cardiology Department</name>
      <address>
        <city>Hamilton</city>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MULTI-MED PLUS Spolka z o.o</name>
      <address>
        <city>Lodz</city>
        <zip>95336</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instytut Kardiologii</name>
      <address>
        <city>Warzawa</city>
        <zip>04-628</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ssusch</name>
      <address>
        <city>Banska Bystrica</city>
        <zip>97401</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kardiologická klinika</name>
      <address>
        <city>Bratislava</city>
        <zip>833 48</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>VUSCH East Slovak Cardiology Institute</name>
      <address>
        <city>Kosice</city>
        <zip>04001</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>H. Univ. La Fe</name>
      <address>
        <city>Valencia</city>
        <zip>46009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsspital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Latvia</country>
    <country>New Zealand</country>
    <country>Poland</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2008</study_first_submitted>
  <study_first_submitted_qc>February 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2008</study_first_posted>
  <last_update_submitted>January 9, 2015</last_update_submitted>
  <last_update_submitted_qc>January 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Ventricular Fibrillation</keyword>
  <keyword>Sudden cardiac death</keyword>
  <keyword>Hospitalization due to heart failure</keyword>
  <keyword>Implantable cardioverter-defibrillator</keyword>
  <keyword>Risk of 1st heart failure hospitalization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Death</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

